2026 NPPES data Ophthalmology Physician NPI 1447232459 M.D.
Verify on CMS →

MARK BERKOWITZ, M.D.

Ophthalmology Physician in STERLING HEIGHTS, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
490
Medicare Part D claims · 188 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.6592/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$1.2K
19 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK BERKOWITZ, M.D. is a Ophthalmology Physician ([object Object]) practicing in STERLING HEIGHTS, Michigan with a Medicare Part D prescribing footprint of 490 claims across 188 beneficiaries — 28% brand-name prescribing . Their CMS MIPS Final Score of 90.6592/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.2K across 19 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK BERKOWITZ, M.D. reported a CMS MIPS final score of 90.6592 out of 100, above the 83.1 national average, and filed 490 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK BERKOWITZ, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK BERKOWITZ, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 11/16/2005

NPI 1447232459

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

490 65% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

90.6592/100 7.559200000000004% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Michigan

How Ophthalmology Physician compares to other specialties among Michigan providers

Michigan providers

Ophthalmology Physician share within Michigan

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Michigan

Medicare quality performance — MIPS

MARK BERKOWITZ, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average

High performer (top quartile)
MIPS Final Score
90.6592/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 90.6592/100 vs national avg 83.1

0%100%National avg83%90.7%
MIPS final score (Ophthalmology Physician) — 90.6592/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK BERKOWITZ, M.D. is a Ophthalmology Physician provider practicing in STERLING HEIGHTS, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1447232459. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK BERKOWITZ, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 44650 DELCO BLVD, STERLING HEIGHTS, MI, 48313, with a listed phone of (586) 254-1770. NPI 1447232459 was issued on 11/16/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BERKOWITZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 490 prescription claims written by this provider, covering 188 Medicare beneficiaries and totaling roughly $31K in drug spend, split 28% brand-name and 72% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.6592/100 for the 2023 performance year (Quality 100, Cost 68.864), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

44650 DELCO BLVD
STERLING HEIGHTS, MI 48313

Provider Details

NPI 1447232459
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 11/16/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.6592
Final Score
Avg: 83.1
100
Quality
68.864
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK BERKOWITZ, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

VISION INSTITUTE OF MICHIGAN PC
STERLING HEIGHTS, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK BERKOWITZ, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

REVANCE THERAPEUTICS, INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to MARK BERKOWITZ, M.D.. To verify MARK BERKOWITZ, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MARK BERKOWITZ, M.D. — brand share 28.0%
Specialty average (est.)

28% brand-name claims vs 72% generic, on 490 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

490
Total Claims
$31K
Total Drug Cost
188
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
749
Total Day Supply
16,552
Brand vs Generic
28% brand / 72% generic
Brand Drug Cost
$22K
Generic Drug Cost
$9K
Antibiotic Claims
43

Patient Demographics

Average Patient Age
74.8 years
Avg HCC Risk Score
1.13
Gender Split
63% female / 37% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
136
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
83
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
39
Methylprednisolone
34
Tobradex
Tobramycin/Dexamethasone
29
Timolol Maleate
23
Cephalexin
12
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
12
Clonidine Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How MARK BERKOWITZ, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

MARK BERKOWITZ, M.D.'s 490 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as BERKOWITZ.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK BERKOWITZ, M.D.'s specialty?
MARK BERKOWITZ, M.D. specializes in Ophthalmology Physician and practices in STERLING HEIGHTS, Michigan. Credentials: M.D..
How much does MARK BERKOWITZ, M.D. prescribe under Medicare Part D?
In 2023, MARK BERKOWITZ, M.D. wrote 490 Medicare Part D claims totaling $31K in drug costs for 188 beneficiaries.
What is MARK BERKOWITZ, M.D.'s Medicare quality score?
MARK BERKOWITZ, M.D. has a CMS MIPS Final Score of 90.6592/100 (Quality: 100, Cost: 68.864). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK BERKOWITZ, M.D. located?
MARK BERKOWITZ, M.D. is located at 44650 DELCO BLVD, STERLING HEIGHTS, MI, 48313. Phone: (586) 254-1770.
What is MARK BERKOWITZ, M.D.'s NPI number?
MARK BERKOWITZ, M.D.'s National Provider Identifier (NPI) is 1447232459, issued on 11/16/2005.
Does MARK BERKOWITZ, M.D. prescribe more brand-name or generic drugs?
MARK BERKOWITZ, M.D.'s prescribing is 28% brand-name and 72% generic drugs by claim count, with $22K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does MARK BERKOWITZ, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK BERKOWITZ, M.D.'s most frequently prescribed drugs include Latanoprost, Neomycin-Polymyxin-Dexameth, Tobramycin-Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK BERKOWITZ, M.D. accept Medicare?
MARK BERKOWITZ, M.D. appears in CMS Medicare data with 490 Part D claims and 188 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK BERKOWITZ, M.D.'s credentials?
MARK BERKOWITZ, M.D.'s NPI is 1447232459 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology